KRONOX · Kronox Lab Sciences Limited · Financials
Market Cap
7.15B INR
Shares
37.10M
Volume · Nov 13
16.66K
Avg daily vol (3M)
631.05K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
1.01B
+1%
FY2026
Net Income
276.6M
+9.3%
FY2026
Operating Cash Flow
238.92M
-26.4%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 | FY2024 |
|---|---|---|---|---|
| INR | 1.05B | 1.01B | 1B | 898.62M |
| INR | 20.99M | 20.48M | 13.82M | 12.89M |
| INR | 1.47M | 1.14M | 0 | 0 |
| INR | 385.59M | 373.03M | 342.71M | 286.08M |
| INR | 99.88M | 96.43M | 89.63M | 72.57M |
| INR | 285.7M | 276.6M | 253.08M | 213.51M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2024–FY2026: 37.09M in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.